Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast
Intra-Cellular Therapies (Nasdaq: ITCI), a biopharmaceutical company specializing in central nervous system (CNS) disorder treatments, has announced a conference call and webcast for August 7, 2024, at 8:30 a.m. Eastern Time. The event will provide a corporate update and discuss financial results for the quarter ending June 30, 2024.
Participants can join the call via phone by using the provided registration link. The webcast will be accessible through the company's website under the Investor Relations section. Interested parties are advised to log in 5-10 minutes early to complete the registration process and install any necessary software.
Intra-Cellular Therapies (Nasdaq: ITCI), un'azienda biofarmaceutica specializzata nella trattamento dei disturbi del sistema nervoso centrale (CNS), ha annunciato una conferenza telefonica e una webcast per il 7 agosto 2024, alle 8:30 ora dell'Est. L'evento fornirà un aggiornamento aziendale e discuterà i risultati finanziari per il trimestre che si è concluso il 30 giugno 2024.
I partecipanti possono unirsi alla chiamata telefonicamente utilizzando il link di registrazione fornito. La webcast sarà accessibile attraverso il sito web dell'azienda nella sezione delle Relazioni con gli Investitori. Le parti interessate sono invitate a collegarsi 5-10 minuti prima per completare il processo di registrazione e installare eventuale software necessario.
Intra-Cellular Therapies (Nasdaq: ITCI), una empresa biofarmacéutica especializada en tratamientos de trastornos del sistema nervioso central (CNS), ha anunciado una conferencia telefónica y una transmisión por webcast para el 7 de agosto de 2024, a las 8:30 a.m. Hora del Este. El evento proporcionará una actualización corporativa y discutirá los resultados financieros para el trimestre que finaliza el 30 de junio de 2024.
Los participantes pueden unirse a la llamada por teléfono utilizando el enlace de registro proporcionado. La transmisión por webcast estará disponible a través del sitio web de la empresa en la sección de Relaciones con Inversores. Se aconseja a los interesados que inicien sesión 5-10 minutos antes para completar el proceso de registro e instalar cualquier software necesario.
Intra-Cellular Therapies (Nasdaq: ITCI)는 중추 신경계(CNS) 장애 치료를 전문으로 하는 바이오 제약 회사로, 2024년 8월 7일 오전 8:30 동부 표준시에 컨퍼런스 콜 및 웨비나를 발표했습니다. 이 행사는 기업 업데이트를 제공하고 2024년 6월 30일로 끝나는 분기의 재무 결과에 대해 논의할 것입니다.
참가자는 제공된 등록 링크를 사용하여 전화를 통해 콜에 참여할 수 있습니다. 웨비나는 회사 웹사이트의 투자자 관계 섹션을 통해 접근할 수 있습니다. 관심 있는 분들은 등록 절차를 완료하고 필요한 소프트웨어를 설치하기 위해 5-10분 일찍 로그인할 것을 권장합니다.
Intra-Cellular Therapies (Nasdaq: ITCI), une société bio-pharmaceutique spécialisée dans les traitements des troubles du système nerveux central (SNC), a annoncé une conférence téléphonique et un webinaire pour le 7 août 2024 à 8h30, heure de l'Est. L'événement proposera une mise à jour de l'entreprise et discutera des résultats financiers pour le trimestre se terminant le 30 juin 2024.
Les participants peuvent se joindre à l'appel par téléphone en utilisant le lien d'inscription fourni. Le webinaire sera accessible via le site web de l'entreprise, dans la section des Relations Investisseurs. Les parties intéressées sont invitées à se connecter 5 à 10 minutes à l'avance pour compléter le processus d'inscription et installer tout logiciel nécessaire.
Intra-Cellular Therapies (Nasdaq: ITCI), ein biopharmazeutisches Unternehmen, das sich auf Behandlungen für Erkrankungen des zentralen Nervensystems (ZNS) spezialisiert hat, hat eine Telefonkonferenz und ein Webcast für den 7. August 2024 um 8:30 Uhr Eastern Time angekündigt. Die Veranstaltung wird ein Unternehmensupdate bieten und die finanziellen Ergebnisse für das am 30. Juni 2024 endende Quartal besprechen.
Teilnehmer können über den bereitgestellten Registrierungslink telefonisch an dem Anruf teilnehmen. Das Webcast wird über die Unternehmenswebsite im Bereich Investor Relations zugänglich sein. Interessierte Parteien werden gebeten, 5-10 Minuten früher einzuchecken, um den Registrierungsprozess abzuschließen und notwendige Software zu installieren.
- None.
- None.
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Wednesday, August 7, 2024, to provide a corporate update and discuss details of the Company's financial results for the quarter ended June 30, 2024.
To attend the live conference call by phone please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call.
The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.
Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406
FAQ
When is Intra-Cellular Therapies (ITCI) hosting its Q2 2024 earnings call?
How can investors access ITCI's Q2 2024 financial results conference call?
What will be discussed during ITCI's Q2 2024 earnings call?
Where can I find the webcast for ITCI's Q2 2024 earnings call?
